Unlock The Potential of LRCH2: A Unique Protein with Multiple Functions

Target Name: LRCH2

NCBI ID: G57631

LRCH2

Other Name(s): KIAA1495 | Leucine-rich repeat and calponin homology domain-containing protein 2 (isoform 1) | dA204F4.4 | LRCH2 variant 1 | leucine-rich repeats and calponin homology (CH) domain containing 2 | Leucine-rich repeat and calponin homology domain-containing protein 2 | Leucine rich repeats and calponin homology domain containing 2, transcript variant 1 | LRCH2_HUMAN | leucine rich repeats and calponin homology domain containing 2

Unlock The Potential of LRCH2: A Unique Protein with Multiple Functions

LRCH2 (KIAA1495) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Kallikrein-related peptidases (KAPs) family, which includes several structurally similar proteins that are involved in the regulation of proteostasis, inflammation, and signaling pathways.

The LRCH2 protein is of particular interest as a potential drug target or biomarker due to its unique structure and function. LRCH2 is a 21-kDa protein that consists of 115 amino acid residues. It has a unique N-terminal region that consists of a short amino acid sequence known as N-伪-helix. This region is involved in the formation of a尾-sheet, which is a common structural feature of proteins that involves the mutual arrangement of amino acids in a specific order.

The LRCH2 protein is also unique due to its role in the regulation of the 纬-secretase pathway, which is a well-established route for the clearance of misfolded proteins in the brain. The 纬-secretase pathway is responsible for breaking down proteins that are prone to misfolding, such as neurotoxins, and is critical for maintaining the health and function of the brain.

LRCH2 has been shown to play a role in the regulation of the 纬-secretase pathway by interacting with the protein 尾-mannoside R, which is a key regulator of the pathway. Studies have shown that LRCH2 can physically interact with 尾-mannoside R and that this interaction is critical for the regulation of 纬-secretase activity.

In addition to its role in the 纬-secretase pathway, LRCH2 has also been shown to be involved in the regulation of other signaling pathways, including the TGF-β pathway and the Wnt pathway. The TGF-β pathway is involved in the regulation of cell growth, differentiation, and survival, while the Wnt pathway is involved in the regulation of cell-cell signaling and the development of tissues.

The unique structure and function of LRCH2 make it an attractive potential drug target or biomarker. Studies have shown that LRCH2 can be targeted by small molecules, including inhibitors of the 纬-secretase pathway. Additionally, LRCH2 has been shown to be involved in several diseases , including neurodegenerative diseases, which makes it an attractive target for the development of new therapies.

In conclusion, LRCH2 is a unique protein that is expressed in various tissues of the body and is involved in the regulation of several signaling pathways, including the 纬-secretase pathway. Its unique structure and function make it an attractive potential drug target or biomarker, and its involvement in several diseases make it a promising target for the development of new therapies. Further research is needed to fully understand the role of LRCH2 in the regulation of these signaling pathways and its potential as a drug target or biomarker.

Protein Name: Leucine Rich Repeats And Calponin Homology Domain Containing 2

Functions: May play a role in the organization of the cytoskeleton

The "LRCH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRCH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets